Brain natriuretic peptide for the prediction of sudden cardiac death and ventricular arrhythmias: A meta-analysis

European Journal of Heart Failure

Volumn 11, Issue 10, 2009, Pages 958-966

  Scott, Paul A ^a   Barry, James ^a   Roberts, Paul R ^a,b   Morgan, John M ^a,b  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Brain natriuretic peptide; Meta analysis; Sudden death; Ventricular arrhythmias

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ARTICLE; CLINICAL TRIAL; DEFIBRILLATOR; HEART VENTRICLE ARRHYTHMIA; HUMAN; META ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SUDDEN DEATH; SYSTEMATIC REVIEW;

AGE FACTORS; AGED; AGED, 80 AND OVER; ARRHYTHMIAS, CARDIAC; BIOLOGICAL MARKERS; CAUSE OF DEATH; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; SEX FACTORS; VENTRICULAR FIBRILLATION; VENTRICULAR FLUTTER;

EID: 70349958189     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfp123     Document Type: Article

References (43)

1. Ezekowitz JA, Rowe BH, Dryden DM, Hooton N, Vandermeer B, Spooner C, McAlister FA. Systematic review: implantable cardioverter defibrillators for adults with left ventricular systolic dysfunction. Ann Intern Med 2007;147: 251-262. (Pubitemid 351664582)
2. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole- Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008;10:933-989.
3. Epstein AE, Dimarco JP, Ellenbogen KA, Estes NA III, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO. ACC/AHA/ HRS 2008 guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: executive summary. Heart Rhythm 2008;5:934-955.
4. Goldberger JJ, Cain ME, Hohnloser SH, Kadish AH, Knight BP, Lauer MS, Maron BJ, Page RL, Passman RS, Siscovick D, Stevenson WG, Zipes DP. American Heart Association/american College of Cardiology Foundation/heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. Heart Rhythm 2008;5:e1-e21.
5. Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol 2007;50:2357-2368.
6. Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 2006;6:31.
7. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7: 177-188.
8. Egger M, Smith GD, Phillips AN. Meta-analysis: principles and procedures. BMJ 1997;315:1533-1537.
9. Deville WL, Buntinx F, Bouter LM, Montori VM, de Vet HC, van der Windt DA, Bezemer PD. Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol 2002;2:9.
10. Lijmer JG, Bossuyt PM, Heisterkamp SH. Exploring sources of heterogeneity in systematic reviews of diagnostic tests. Stat Med 2002;21:1525-1537.
11. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560.
12. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088-1101.
13. Christ M, Sharkova J, Bayrakcioglu S, Herzum I, Mueller C, Grimm W. B-type natriuretic peptide levels predict event-free survival in patients with implantable cardioverter defibrillators. Eur J Heart Fail 2007;9:272-279.
14. Konstantino Y, Kusniec J, Reshef T, David-Zadeh O, Mazur A, Strasberg B, Battler A, Haim M. Inflammatory biomarkers are not predictive of intermediateterm risk of ventricular tachyarrhythmias in stable CHF patients. Clin Cardiol 2007; 30:408-413.
15. Vrtovec B, Okrajsek R, Golicnik A, Ferjan M, Starc V, Schlegel TT, Radovancevic B. Atorvastatin therapy may reduce the incidence of sudden cardiac death in patients with advanced chronic heart failure. J Cardiac Fail 2008;14:140-144.
16. Gardiwal A, Yu H, Oswald H, Luesebrink U, Ludwig A, Pichlmaier AM, Drexler H, Klein G. Right ventricular pacing is an independent predictor for ventricular tachycardia/ ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator. Europace 2008;10:358-363.
17. Simon T, Becker R, Voss F, Bikou O, Hauck M, Licka M, Katus HA, Bauer A. Elevated B-type natriuretic peptide levels in patients with nonischemic cardiomyopathy predict occurrence of arrhythmic events. Clin Res Cardiol 2008;97:306-309.
18. Berger R, Huelsmann M, Strecker K, Moertl D, Moser P, Bojic A, Pacher R. Neurohormonal risk stratification for sudden death and death owing to progressive heart failure in chronic heart failure. Eur J Clin Invest 2005;35:24-31.
19. Bayes-Genis A, Vazquez R, Puig T, Fernandez-Palomeque C, Fabregat J, Bardaji A, Pascual-Figal D, Ordonez-Llanos J, Valdes M, Gabarrus A, Pavon R, Pastor L, Gonzalez Juanatey JR, Almendral J, Fiol M, Nieto V, Macaya C, Cinca J, Bayes de Luna A. Left atrial enlargement and NT-proBNP as predictors of sudden cardiac death in patients with heart failure. Eur J Heart Fail 2007;9:802-807.
20. Tapanainen JM, Lindgren KS, Makikallio TH, Vuolteenaho O, Leppaluoto J, Huikuri HV. Natriuretic peptides as predictors of non-sudden and sudden cardiac death after acute myocardial infarction in the beta-blocking era. J Am Coll Cardiol 2004;43:757-763.
21. Tigen K, Karaahmet T, Kahveci G, Tanalp AC, Bitigen A, Fotbolcu H, Bayrak F, Mutlu B, Basaran Y. N-terminal pro brain natriuretic peptide to predict prognosis in dilated cardiomyopathy with sinus rhythm. Heart Lung Circ 2007;16:290-294.
22. Watanabe J, Shinozaki T, Shiba N, Fukahori K, Koseki Y, Karibe A, Sakuma M, Miura M, Kagaya Y, Shirato K. Accumulation of risk markers predicts the incidence of sudden death in patients with chronic heart failure. Eur J Heart Fail 2006;8: 237-242.
23. Berger R, Huelsman M, Strecker K, Bojic A, Moser P, Stanek B, Pacher R. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 2002;105:2392-2397.
24. Winkler K, Wanner C, Drechsler C, Lilienthal J, Marz W, Krane V. Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients. Eur Heart J 2008;29:2092-2099.
25. Yu H, Oswald H, Gardiwal A, Lissel C, Klein G. Comparison of N-terminal probrain natriuretic peptide versus electrophysiologic study for predicting future outcomes in patients with an implantable cardioverter defibrillator after myocardial infarction. Am J Cardiol 2007;100:635-639.
26. Verma A, Kilicaslan F, Martin DO, Minor S, Starling R, Marrouche NF, Almahammed S, Wazni OM, Duggal S, Zuzek R, Yamaji H, Cummings J, Chung MK, Tchou PJ, Natale A. Preimplantation B-type natriuretic peptide concentration is an independent predictor of future appropriate implantable defibrillator therapies. Heart 2006;92:190-195.
27. Manios EG, Kallergis EM, Kanoupakis EM, Mavrakis HE, Kambouraki DC, Arfanakis DA, Vardas PE. Amino-terminal pro-brain natriuretic peptide predicts ventricular arrhythmogenesis in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillators. Chest 2005;128:2604-2610.
28. Klein G, Lissel C, Fuchs AC, Gardiwal A, Oswald H, Desousa M, Pichlmaier AM, Lichtinghagen R, Geerlings H, Lippolt P, Niehaus M, Drexler H, Korte T. Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study. Europace 2006;8:618-624.
29. Blangy H, Sadoul N, Dousset B, Radauceanu A, Fay R, Aliot E, Zannad F. Serum BNP, hs-C-reactive protein, procollagen to assess the risk of ventricular tachycardia in ICD recipients after myocardial infarction. Europace 2007;9:724-729.
30. Budeus M, Reinsch N, Wieneke H, Sack S, Erbel R. The prediction of ICD therapy in multicenter automatic defibrillator implantation trial (MADIT) II like patients: a retrospective analysis. Indian Pacing Electrophysiol J 2008;8:80-93.
31. Klingenberg R, Zugck C, Becker R, Schellberg D, Heinze G, Kell R, Remppis A, Schoels W, Katus HA, Dengler TJ. Raised B-type natriuretic peptide predicts implantable cardioverter-defibrillator therapy in patients with ischaemic cardiomyopathy. Heart 2006;92:1323-1324.
32. Nagahara D, Nakata T, Hashimoto A, Wakabayashi T, Kyuma M, Noda R, Shimoshige S, Uno K, Tsuchihashi K, Shimamoto K. Predicting the need for an implantable cardioverter defibrillator using cardiac metaiodobenzylguanidine activity together with plasma natriuretic peptide concentration or left ventricular function. J Nucl Med 2008;49:225-233.
33. Doust JA, Pietrzak E, Dobson A, Glasziou P. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ 2005;330:625.
34. Mozaffarian D, Anker SD, Anand I, Linker DT, Sullivan MD, Cleland JG, Carson PE, Maggioni AP, Mann DL, Pitt B, Poole-Wilson PA, Levy WC. Prediction of mode of death in heart failure: the Seattle Heart Failure Model. Circulation 2007; 116:392-398.
35. Reiter MJ. Effects of mechano-electrical feedback: potential arrhythmogenic influence in patients with congestive heart failure. Cardiovasc Res 1996;32:44-51.
36. Franz MR, Cima R, Wang D, Profitt D, Kurz R. Electrophysiological effects of myocardial stretch and mechanical determinants of stretch-activated arrhythmias. Circulation 1992;86:968-978.
37. Makikallio TH, Barthel P, Schneider R, Bauer A, Tapanainen JM, Tulppo MP, Schmidt G, Huikuri HV. Prediction of sudden cardiac death after acute myocardial infarction: role of Holter monitoring in the modern treatment era. Eur Heart J 2005;26:762-769.
38. Bailey JJ, Berson AS, Handelsman H, Hodges M. Utility of current risk stratification tests for predicting major arrhythmic events after myocardial infarction. J Am Coll Cardiol 2001;38:1902-1911.
39. Gehi AK, Stein RH, Metz LD, Gomes JA. Microvolt T-wave alternans for the risk stratification of ventricular tachyarrhythmic events: a meta-analysis. J Am Coll Cardiol 2005;46:75-82.
40. de Sousa MR, Morillo CA, Rabelo FT, Nogueira Filho AM, Ribeiro AL. Nonsustained ventricular tachycardia as a predictor of sudden cardiac death in patients with left ventricular dysfunction: a meta-analysis. Eur J Heart Fail 2008; 10:1007-1014.
41. McGowan JH, Cleland JGF. Reliability of reporting left ventricular systolic function by echocardiography: A systematic review of 3 methods. Am Heart J 2003;146: 388-397.
42. Ellenbogen KA, Levine JH, Berger RD, Daubert JP, Winters SL, Greenstein E, Shalaby A, Schaechter A, Subacius H, Kadish A. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Circulation 2006;113:776-782.
43. Moayyedi P. Meta-analysis: Can we mix apples and oranges? Am J Gastroenterol 2004;99:2297-2301.